Dev stage bio with some contract mfg facilities they owned (Avid). Built up Avid facilities while drug was still in trials. Longs cheered this on.
Drug flopped, Avid was a success. CDMO longs did well if they held through the long winter, but based on mfg ops, not the drug candidate (bavituximab).
The other example I would list is still a work in progress. CVM.